T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma
Clinical trial NCT06783270 · RECRUITING
Trial details
- NCT number
- NCT06783270
- Sponsor
- Inge Marie Svane
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-16
- Primary completion
- 2027-01-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.